Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(18%)
Results Posted
20%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_1
1
9%
Ph phase_2
3
27%
Ph not_applicable
7
64%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
3(27.3%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Completed5
unknown2
Recruiting1
Terminated1
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (9.1%)
Phase 23 (27.3%)
N/A7 (63.6%)

Trials by Status

completed545%
recruiting19%
terminated19%
active_not_recruiting19%
unknown218%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11